Literature DB >> 19701813

Virilizing adrenocortical carcinoma in a child with Turner syndrome and somatic TP53 gene mutation.

Jung-Hee Ko1, Hyo Sung Lee, Jeong Hong, Jin Soon Hwang.   

Abstract

Virilizing adrenocortical carcinoma and Turner syndrome have opposite clinical manifestations in some aspects. Here, we report on the first case of virilizing adrenocortical carcinoma in a girl with Turner syndrome. A 2 10/12-year-old girl presented pubic hair of Tanner stage III with clitomegaly, deepening of her voice, and tall stature. No other morphologic anomaly was found. Biochemical assessment revealed normal electrolytes with pronounced elevation of adrenal androgens. She was found to have a large mass of the left adrenal gland on abdominal computed tomography scan. She underwent complete resection of the mass, and pathology was consistent with adrenocortical carcinoma. She was tested for TP53 gene mutation, and we found a de novo TP53 gene mutation (Val143Ala) as well as a 45,X karyotype.

Entities:  

Mesh:

Year:  2009        PMID: 19701813     DOI: 10.1007/s00431-009-1051-8

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Various forms of mutant p53 confer sensitivity to cisplatin and doxorubicin in bladder cancer cells.

Authors:  F L Chang; M D Lai
Journal:  J Urol       Date:  2001-07       Impact factor: 7.450

Review 2.  Turner's syndrome in adulthood.

Authors:  M Elsheikh; D B Dunger; G S Conway; J A H Wass
Journal:  Endocr Rev       Date:  2002-02       Impact factor: 19.871

3.  Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.

Authors:  E K Pivnick; W L Furman; G V Velagaleti; J J Jenkins; N A Chase; R C Ribeiro
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

Review 4.  TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes.

Authors:  A Petitjean; M I W Achatz; A L Borresen-Dale; P Hainaut; M Olivier
Journal:  Oncogene       Date:  2007-04-02       Impact factor: 9.867

5.  An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma.

Authors:  R C Ribeiro; F Sandrini; B Figueiredo; G P Zambetti; E Michalkiewicz; A R Lafferty; L DeLacerda; M Rabin; C Cadwell; G Sampaio; I Cat; C A Stratakis; R Sandrini
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 6.  Adrenocortical carcinoma: clinical and laboratory observations.

Authors:  B L Wajchenberg; M A Albergaria Pereira; B B Medonca; A C Latronico; P Campos Carneiro; V A Alves; M C Zerbini; B Liberman; G Carlos Gomes; M A Kirschner
Journal:  Cancer       Date:  2000-02-15       Impact factor: 6.860

7.  Hot-spot mutants of p53 core domain evince characteristic local structural changes.

Authors:  K B Wong; B S DeDecker; S M Freund; M R Proctor; M Bycroft; A R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

8.  Acromegaly accompanied by Turner syndrome with 47,XXX/45,X/46,XX mosaicism.

Authors:  Masanori Yamazaki; Ai Sato; Shin-ichi Nishio; Teiji Takeda; Takahide Miyamoto; Miyuki Katai; Kiyoshi Hashizume
Journal:  Intern Med       Date:  2009-03-16       Impact factor: 1.271

Review 9.  Childhood adrenocortical tumours.

Authors:  R C Ribeiro; B Figueiredo
Journal:  Eur J Cancer       Date:  2004-05       Impact factor: 9.162

10.  Normative data for the steroidogenic response of mineralocorticoids and their precursors to adrenocorticotropin in a healthy pediatric population.

Authors:  G Lashansky; P Saenger; J Dimartino-Nardi; T Gautier; D Mayes; G Berg; E Reiter
Journal:  J Clin Endocrinol Metab       Date:  1992-12       Impact factor: 5.958

View more
  2 in total

1.  Dual diagnoses in 152 patients with Turner syndrome: Knowledge of the second condition may lead to modification of treatment and/or surveillance.

Authors:  Kelly L Jones; Erin A McNamara; Mauro Longoni; Danny E Miller; Mersedeh Rohanizadegan; Laura A Newman; Frances Hayes; Lynne L Levitsky; Betty L Herrington; Angela E Lin
Journal:  Am J Med Genet A       Date:  2018-08-06       Impact factor: 2.802

2.  Pubertal development among girls with classical congenital adrenal hyperplasia initiated on treatment at different ages.

Authors:  Bindu Kulshreshtha; Marumudi Eunice; Ariachery C Ammini
Journal:  Indian J Endocrinol Metab       Date:  2012-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.